A Study to Compare Digital Disease Monitoring of Patients With csU (Telemedicine to Face-to-Face Visits) in Germany

Active, not recruitingOBSERVATIONAL
Enrollment

116

Participants

Timeline

Start Date

June 11, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Chronic Spontaneous Urticaria
Interventions
OTHER

Collection of patient data

This non-interventional study and will not influence treatment decisions

Trial Locations (20)

10117

Novartis Investigative Site, Berlin

13086

Novartis Investigative Site, Berlin

22391

Novartis Investigative Site, Hamburg

28779

Novartis Investigative Site, Bremen

42897

Novartis Investigative Site, Remscheid

44143

Novartis Investigative Site, Dortmund

45879

Novartis Investigative Site, Gelsenkirchen

48683

Novartis Investigative Site, Ahaus

49809

Novartis Investigative Site, Lingen Ems

55131

Novartis Investigative Site, Mainz

56068

Novartis Investigative Site, Koblenz

56242

Novartis Investigative Site, Selters

59174

Novartis Investigative Site, Kamen

80377

Novartis Investigative Site, München

85354

Novartis Investigative Site, Freising

90402

Novartis Investigative Site, Nuremberg

04103

Novartis Investigative Site, Leipzig

06122

Novartis Investigative Site, Halle

01109

Novartis Investigative Site, Dresden

07548

Novartis Investigative Site, Gera

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY